Literature DB >> 8689153

Prognostic significance and surgical management of lymph node metastasis in gastric cancer.

M Noguchi1, I Miyazaki.   

Abstract

Regional lymph node metastasis is a critical prognostic factor in gastric cancer, and extended lymph node dissection and routine microscopic examination of all resected nodes could potentially provide accurate information regarding lymph node status. On the other hand, the therapeutic value of extended lymph node dissection is controversial. While retrospective and prospective nonrandomized comparative studies have shown that extended lymph node dissection significantly improves the survival rate, two prospective randomized trials have failed to demonstrate the efficacy of extended dissection, although the number of patients in these studies was limited. There is a further, ongoing, trial involving a larger series of patients; the final results of this study should help to determine whether extended lymph node dissection is of therapeutic or merely prognostic value in gastric cancer.

Entities:  

Mesh:

Year:  1996        PMID: 8689153

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  8 in total

1.  Prognostic factors in gastric cancer.

Authors:  F Pacelli; G B Doglietto; P Caprino
Journal:  Ann Surg       Date:  1999-09       Impact factor: 12.969

2.  Clinical Influence of the Lymph Node Ratio on Lymph Node Metastasis-positive Gastric Cancer Patients Who Receive Curative Treatment.

Authors:  Toru Aoyama; Kesikeu Komori; Ayako Tamagawa; Masato Nakazano; Kentaro Hara; Itaru Hashimoto; Hiroshi Tamagawa; Kenki Segami; Yukio Maezawa; Kazuki Kano; Takashi Oshima; Norio Yukawa; Yasushi Rino
Journal:  In Vivo       Date:  2022 Mar-Apr       Impact factor: 2.155

3.  Short-Term Outcome in Patients Undergoing Gastrectomy with D2 Lymphadenectomy for Carcinoma Stomach.

Authors:  Ganesh Vadthya; Vishnu Prasad Nelamangala Ramakrishnaiah; Srinivasan Krishnamachari
Journal:  Indian J Surg Oncol       Date:  2017-02-13

4.  The effect of adjuvant chemotherapy on stage IV (T4N1-3M0 and T1-3N3M0) gastric cancer.

Authors:  Tae Kyung Ha; Min Sung Jung; Kang Hong Lee; Kyeong Geun Lee; Sung Joon Kwon
Journal:  Cancer Res Treat       Date:  2009-03-31       Impact factor: 4.679

5.  Gastrectomy with D2 Lymphadenectomy for Carcinoma of the Stomach in a Stand-alone Cancer Centre in Rural India.

Authors:  Nizamudheen Mangalasseri Pareekutty; Sachin Kadam; Basavaraj Ankalkoti; Satheesan Balasubramanian; Bindu Anilkumar
Journal:  Indian J Surg Oncol       Date:  2020-05-10

6.  The prognostic advantage of preoperative intratumoral injection of OK-432 for gastric cancer patients.

Authors:  A Gochi; K Orita; S Fuchimoto; N Tanaka; N Ogawa
Journal:  Br J Cancer       Date:  2001-02       Impact factor: 7.640

7.  When Eastern Surgeons Meet Western Patients: A Pilot Study of Gastrectomy with Lymphadenectomy in Caucasian Patients at a Single Korean Institute.

Authors:  Masatoshi Nakagawa; Yoon Young Choi; Ji Yeong An; Sang Hyuk Seo; Hyun Beak Shin; Hui Jae Bang; Shuangxi Li; Hyung Il Kim; Jae Ho Cheong; Woo Jin Hyung; Sung Hoon Noh
Journal:  Yonsei Med J       Date:  2016-09       Impact factor: 2.759

8.  Survival outcomes after D1 and D2 lymphadenectomy with R0 resection in stage II-III gastric cancer: Longitudinal follow-up in a single center.

Authors:  Adam Uslu; Baha Zengel; Enver İlhan; Ahmet Aykas; Cenk Şimşek; Orhan Üreyen; Ali Duran; Gökalp Okut
Journal:  Turk J Surg       Date:  2018-07-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.